Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
Latest Information Update: 23 Aug 2024
At a glance
- Drugs Cannabidivarin (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- 21 Aug 2024 Planned End Date changed from 1 Jul 2024 to 1 Dec 2025.
- 21 Aug 2024 Planned primary completion date changed from 1 Jul 2024 to 1 Dec 2025.
- 22 Sep 2023 Planned End Date changed from 31 Jul 2023 to 1 Jul 2024.